SCHEMBL353790

SCHEMBL353790

O=C(CCCCCn1c2ccccc2c(=O)c2ccccc21)ON1C(=O)CCC1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 7/20 0.51
HDAC6 Q9UBN7 7/20 0.51
HDAC3 O15379 1/20 0.51
HDAC4 P56524 1/20 0.51
HDAC7 Q8WUI4 1/20 0.51
HDAC2 Q92769 1/20 0.51
HDAC10 Q969S8 1/20 0.51
HDAC11 Q96DB2 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC9 Q9UKV0 1/20 0.51
HDAC5 Q9UQL6 1/20 0.51
FABP4 P15090 3/20 0.50
FABP5 Q01469 3/20 0.50
SLC6A4 P31645 2/20 0.47
SLC6A2 P23975 1/20 0.47
HRH1 P35367 1/20 0.47
MAPT P10636 3/20 0.44
TP53 P04637 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL353722 0.91 HDAC1 (0.46) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL357128 0.88 HDAC1 (0.41) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL353757 0.86 NPC1 (0.49) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL354525 0.84 HSD17B10 (0.40) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL355499 0.79 TNF (0.62) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL355352 0.77 FABP4 (0.82) HDAC1HDAC6HDAC3HDAC4HDAC7
SCHEMBL4960230 0.77 SMN1; SMN2 (0.42) SMN1; SMN2
SCHEMBL379163 0.77 SMN1; SMN2 (0.42) SMN1; SMN2
SCHEMBL905404 0.77 SMN1; SMN2 (0.42) SMN1; SMN2
SCHEMBL905722 0.77 SMN1; SMN2 (0.42) SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100304407-A1 Fluorescence Lifetime and Fluorescence Assays EDINBURGH INSTRUMENTS LIMITED (GB) 2010-12-02 US claimed
US-8334387-B2 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2012-12-18 US disclosed
US-8334387-B2 Method for measuring aromatase activity GE HEALTHCARE UK LIMITED (GB) 2012-12-18 US disclosed
US-20120015373-A1 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS GE HEALTHCARE UK LIMITED (GB) 2012-01-19 US disclosed
US-20120015373-A1 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS GE HEALTHCARE UK LIMITED (GB) 2012-01-19 US disclosed
US-20120015373-A1 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS GE HEALTHCARE UK LIMITED (GB) 2012-01-19 US disclosed
US-8034558-B2 Incubating dye of given formula with biological material, measuring fluorescence lifetime; lectins/glycoproteins, biotin/streptavidin, DNA/RNA GE HEALTHCARE UK LIMITED (GB) 2011-10-11 US disclosed
US-8034558-B2 Incubating dye of given formula with biological material, measuring fluorescence lifetime; lectins/glycoproteins, biotin/streptavidin, DNA/RNA GE HEALTHCARE UK LIMITED (GB) 2011-10-11 US disclosed
US-8034558-B2 Incubating dye of given formula with biological material, measuring fluorescence lifetime; lectins/glycoproteins, biotin/streptavidin, DNA/RNA GE HEALTHCARE UK LIMITED (GB) 2011-10-11 US disclosed
EP-1497452-B1 METHODS FOR MEASURING ENZYME ACTIVITY GE HEALTHCARE UK LTD (GB) 2011-03-02 EP disclosed
US-7125682-B2 Methods for measuring protein kinase and phosphatase activity GE HEALTHCARE UK LIMITED (GB) 2006-10-24 US disclosed
EP-1497452-A2 METHODS FOR MEASURING ENZYME ACTIVITY Amersham Biosciences UK Limited (GB) 2005-01-19 EP disclosed
EP-1497453-A1 METHODS FOR MEASURING PROTEIN KINASE AND PHOSPHATASE ACTIVITY Amersham Biosciences UK Limited (GB) 2005-01-19 EP disclosed
US-20040191792-A1 Acridone derivatives as labels for fluorescence detection of target materials GE HEALTHCARE UK LIMITED (GB) 2004-09-30 US disclosed
EP-1392776-A2 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS Amersham Biosciences UK Limited (GB) 2004-03-03 EP disclosed
US-20030228646-A1 Methods for measuring protein kinase and phosphatase activity TTP LABTECH LIMITED (GB) 2003-12-11 US disclosed
US-20030228609-A1 Methods for measuring enzyme activity TTP LABTECH LIMITED (GB) 2003-12-11 US disclosed
WO-2003089665-A1 METHODS FOR MEASURING PROTEIN KINASE AND PHOSPHATASE ACTIVITY AMERSHAM BIOSCIENCES UK LIMITED (GB) 2003-10-30 WO disclosed
WO-2003089663-A2 METHODS FOR MEASURING ENZYME ACTIVITY AMERSHAM BIOSCIENCES UK LIMITED (GB) 2003-10-30 WO disclosed
WO-2002099424-A2 ACRIDONE DERIVATIVES AS LABELS FOR FLUORESCENCE DETECTION OF TARGET MATERIALS AMERSHAM BIOSCIENCES UK LIMITED (GB) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040191792-A1 Acridone derivatives as labels for fluorescence detection of target materials ACR, ARSA, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 HDAC1 2453/4885HDAC6 1983/4885HDAC3 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.